These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11668426)

  • 1. The Effect of Low Molecular Weight Heparins on Fracture Healing.
    Kapetanakis S; Nastoulis E; Demesticha T; Demetriou T
    Open Orthop J; 2015; 9():226-36. PubMed ID: 26161162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Natural Hirudin and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis in Aged Patients with Intertrochanteric Fracture.
    Zhang Z; Li Z; Li J; Liu L
    Sci Rep; 2018 Jun; 8(1):8847. PubMed ID: 29891906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke.
    Song J; Lyu Y; Wang M; Zhang J; Gao L; Tong X
    Front Physiol; 2018; 9():84. PubMed ID: 29487537
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypersensitivity to nadroparin calcium : case report and review of the literature.
    Ebo DG; Haine SE; Hagendorens MM; Bridts CH; Conraads VM; Vorlat A; Vrints CJ; De Clerck LS; Stevens WJ
    Clin Drug Investig; 2004; 24(7):421-6. PubMed ID: 17516728
    [No Abstract]   [Full Text] [Related]  

  • 5. Low molecular weight heparins: the optimal treatment for venous thromboembolism.
    Daskalopoulos ME; Daskalopoulou SS; Liapis CD
    Curr Med Res Opin; 2004 Jul; 20(7):1001-5. PubMed ID: 15265244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant hirudin in the prevention of venous thromboembolism in patients undergoing elective hip surgery.
    Agnelli G; Sonaglia F
    Semin Thromb Hemost; 1997; 23(2):143-8. PubMed ID: 9200338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
    Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
    Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparins in the outpatient management of venous thromboembolism.
    Bick RL
    Semin Thromb Hemost; 1999; 25 Suppl 3():97-9. PubMed ID: 10549723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hirudins for prophylaxis and treatment of venous thromboembolism.
    Prisco D; Falciani M; Antonucci E; Gensini GF
    Semin Thromb Hemost; 2001 Oct; 27(5):543-9. PubMed ID: 11668426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.